Olaptesed
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Olaptesed, covering 2020-07-08 to 2020-07-08. Get the full timeline:
Most recent: Clinical Trial Update: Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer [Phase 1, Phase 2]